Therefore, the therapeutic upregulation of hsa-miR-3941 may combine the direct blockage of viral expression through 3′-UTR targeting with the inhibition of PI3K/AKT pathway to reduce viral infection. This evidence concerns the gene AKT1 and viral infectious disease.